Business UpdateMay 7, 2026, 08:31 AM
Milestone Scientific Expands CompuFlo® Medical Business Utilization
AI Summary
Milestone Scientific Inc. provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization and clinical engagement. The CompuFlo® Advisor Program, launched in February 2026, is driving procedural use across multiple Medicare and commercial payer jurisdictions, with active epidural procedures being performed. The company is also expanding its national sales footprint and collaborating with leading academic institutions to support clinical validation and training, all aimed at strengthening its commercial and reimbursement infrastructure.
Key Highlights
- CompuFlo® Advisor Program launched in February 2026, initiating procedural use across key MAC jurisdictions.
- Program active in NJ, FL, PA, NY, TN, TX, GA, with expansion underway into Noridian and NGS MAC regions.
- Active epidural procedures are being performed using CompuFlo®, with initial cases submitted to Medicare and commercial payers.
- Expanding national sales footprint through consultant partners across NJ, NY, PA, FL, TX, WA, CA, OR, CO.
- Collaborating with academic institutions like University of Texas, Kansas, and Minnesota for clinical validation.
- CompuFlo® is currently associated with CPT® Category III code 0777T, aiming for Category I designation.
Price Impact
More from MLSS